Good morning :)
Place Order
Add to Watchlist

Dr Agarwal's Eye Hospital Ltd

DRAGARWQ

Dr Agarwal's Eye Hospital Ltd

DRAGARWQ
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹2,472 cr, stock is ranked 1,041
Moderate RiskStock is 2.69x as volatile as Nifty
5,280.000.57% (+30.00)
5,280.000.57% (+30.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹2,472 cr, stock is ranked 1,041
Moderate RiskStock is 2.69x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹2,472 cr, stock is ranked 1,041
Moderate RiskStock is 2.69x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
48.9715.730.05%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.276.550.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr. Agarwal's Eye Hospital Limited is an eye care company that provides nursing homes; clinics; medical, research and other institutions and establishments for eye care and treatment, and other healthcare facilities.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 13.52%, vs industry avg of 10.02%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.47% to 0.53%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 31.21%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue136.84150.19155.62172.03178.60140.62202.47269.65324.27364.69
Raw Materialssubtract17.7817.5218.9618.2322.5915.0823.6730.6835.95252.38
Power & Fuel Costsubtract2.903.082.883.302.532.102.663.405.74
Employee Costsubtract29.2632.4931.9833.7735.6332.1738.5153.2663.78
Selling & Administrative Expensessubtract25.1328.4731.4656.8343.0032.4943.2460.4673.59
Operating & Other expensessubtract49.1844.7743.7927.9425.0926.9834.4844.2348.05
Depreciation/Amortizationsubtract8.538.749.7810.9121.2419.1020.3920.1826.6133.65
Interest & Other Itemssubtract4.544.163.413.628.596.967.218.048.3010.56
Taxes & Other Itemssubtract-0.513.646.585.516.267.188.2112.4815.8917.61
EPS0.0615.5714.4325.3629.09-3.0651.2878.5598.64107.43
DPS0.801.501.201.500.000.003.003.002.505.00
Payout ratio12.530.100.080.060.000.000.060.040.030.05

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dr Agarwal's Eye Hospital Ltd53.3315.730.05%
Apollo Hospitals Enterprise Ltd118.7514.580.22%
Max Healthcare Institute Ltd99.2012.480.14%
Fortis Healthcare Ltd78.255.480.16%

Price Comparison

Compare DRAGARWQ with any stock or ETF
Compare DRAGARWQ with any stock or ETF
DRAGARWQ
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.90%0.00%0.96%0.83%26.31%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.28%0.63%0.64%0.65%0.83%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 8, 2024

Interim
Interim | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Nov 8, 2024

Cash Dividend

Ex DateEx DateAug 19, 2024

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Aug 19, 2024

Cash Dividend

Ex DateEx DateOct 31, 2023

Interim
Interim | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Oct 31, 2023

Cash Dividend

Ex DateEx DateSep 14, 2023

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Sep 14, 2023

Cash Dividend

Ex DateEx DateSep 6, 2022

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Sep 6, 2022

News & Opinions
Corporate
Dr Agarwals Eye Hospital fixes record date for Dividend

Dr Agarwals Eye Hospital has fixed 8th November 2024 as the record date for the purpose of interim dividend.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Board of Dr Agarwals Eye Hospital recommends Interim dividend

Dr Agarwals Eye Hospital announced that the Board of Directors of the Company at its meeting held on 29 October 2024, inter alia, have recommended the Interim dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 12.39% in the September 2024 quarter

Net profit of Dr Agarwal's Eye Hospital rose 12.39% to Rs 14.15 crore in the quarter ended September 2024 as against Rs 12.59 crore during the previous quarter ended September 2023. Sales rose 21.52% to Rs 102.19 crore in the quarter ended September 2024 as against Rs 84.09 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales102.1984.09 22 OPM %29.2427.60 - PBDT28.4922.99 24 PBT19.1316.65 15 NP14.1512.59 12 Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital declare Quarterly Result

Dr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 29 October 2024Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital opens new branch at Kovilpatti, Tamil Nadu

Dr Agarwals Eye Hospital announced that a new branch of the Company located at 'Kovilpatti, Tamil Nadu' commences its operation with effect from 23 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital announces cessation of director

Dr Agarwals Eye Hospital announced that Sanjay Anand (DIN: 02501139), ceases to be an Independent Director of the Company, with effect from 08 September 2024, consequent to the completion of the second term of five (5) consecutive years.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital AGM scheduled

Dr Agarwals Eye Hospital announced that the Annual General Meeting (AGM) of the company will be held on 26 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 22.27% in the June 2024 quarter

Net profit of Dr Agarwal's Eye Hospital rose 22.27% to Rs 14.11 crore in the quarter ended June 2024 as against Rs 11.54 crore during the previous quarter ended June 2023. Sales rose 27.33% to Rs 100.02 crore in the quarter ended June 2024 as against Rs 78.55 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales100.0278.55 27 OPM %31.4028.84 - PBDT28.7821.39 35 PBT18.9115.54 22 NP14.1111.54 22 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Dr Agarwals Eye Hospital schedules board meeting

Dr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 25 July 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live